Skip to page content

Controlled Substances and Illegal Drugs

Featured

Report

Synthetic Opioids: An Unprecedented Crisis

Aug 29, 2019

The rise of fentanyl and other synthetic opioids is unlike any drug crisis in U.S. history. Limiting policy responses to existing approaches will likely be insufficient and may condemn many people to early deaths.
Report

How Is the Cannabis Market in Washington State Changing?

Aug 2, 2019

This report provides detailed information about state-legal cannabis production and sales in Washington, as well as insights about the total amount of THC obtained from legal and illegal sources.

Explore Controlled Substances and Illegal Drugs

Journal Article

How High: Differences in the Developments of Cannabis Markets in Two Legalized States

This paper is the first to examine cannabis market data from Washington alongside that from Oregon, two states that are similar in regard to legalizing retail sales of cannabis but differ in terms of their regulatory frameworks.

Apr 13, 2021
Journal Article

Acknowledging and Monitoring the Costs of Seriously Regulating Cannabis

Wilkins & Rychert highlight challenges to achieving the Cannabis Legalization and Control Bill's objectives of reducing cannabis use and harms.

Apr 13, 2021
Journal Article

Capsule Commentary for Azcarate Et Al., Medical Reasons for Marijuana Use, Forms of Use, and Patient Perception of Physician Attitudes Among the US Population

Commentary on an article by Azcarate et al., assessing U.S. adults' motivations for and perceived physician attitudes towards medical cannabis use.

Apr 13, 2021
Journal Article

Prescribers and Naloxone Pharmacy Claims

Commentary on an article by Truong, Patil, and Rich, on the benefits and dangers of naloxone prescriptions.

Apr 13, 2021
Journal Article

Does Marijuana Legalization Affect Work Capacity? Evidence from Workers' Compensation Benefits

We study the effect of state recreational marijuana laws on workers' compensation benefit receipt among adults 40–62 years old.

Mar 23, 2021
Journal Article

The Evolving Consequences of OxyContin Reformulation on Drug Overdoses

In this paper, we find that over a longer time horizon, OxyContin reformulation stimulated illicit drug markets to grow and evolve.

Mar 17, 2021
Journal Article

Multiplying the Impact of Opioid Settlement Funds by Investing in Primary Prevention

In this Perspective, we describe three strategies hospitals can use to multiply the reach of their opioid settlement funding by addressing root causes of opioid use through primary prevention.

Mar 17, 2021
Report

An Empirical Assessment of the U.S. Army's Enlistment Waiver Policies: An Examination in Light of Emerging Societal Trends in Behavioral Health and the Legalization of Marijuana

This report documents an analysis of the performance of U.S. Army recruits who receive waivers, as well as those with a documented history of marijuana, attention-deficit/hyperactivity disorder, depression, or anxiety.

Mar 11, 2021
Journal Article

Is the Rise in Illicit Opioids Affecting Labor Supply and Disability Claiming Rates?

Researchers examined how increased use of illicit opioids such as heroin and fentanyl affected labor market participation and claims for disability insurance.

Mar 10, 2021
Journal Article

Heroin Use Cannot Be Measured Adequately with a General Population Survey

Here we explore the important case of using General Population Surveys to estimate frequent heroin use.

Mar 5, 2021
Multimedia

The Opioid Crisis and State & Federal Policies: It’s More Complicated Than You Think

In this video, Bradley Stein presents an exploration of recent federal and state policies related to the opioid crisis and the sometimes unanticipated consequences.

Feb 19, 2021
Journal Article

Racial/ethnic Differences in Prescription Opioid Misuse and Heroin Use Among a National Sample, 1999–2018

We compared relative prevalences across 6 racial/ethnic groups for prescription opioid misuse analyses and 4 racial/ethnic groups for heroin analyses.

Feb 19, 2021
Journal Article

Individual and Community Factors Associated with Naloxone Co-prescribing Among Long-term Opioid Patients: A Retrospective Analysis

This retrospective analysis examines naloxone co-prescribing in the general population and assess how co-prescribing varies by individual and community characteristics.

Feb 19, 2021
Journal Article

Patient, Prescriber, and Community Factors Associated with Filled Naloxone Prescriptions Among Patients Receiving Buprenorphine 2017–18

This retrospective analysis examines filled naloxone prescriptions among patients receiving buprenorphine treatment and assesses how rates of filled naloxone prescriptions varies by patient, prescriber, and community characteristics.

Feb 19, 2021
Journal Article

Mental Health, Physical Health, and Cultural Characteristics Among American Indians/Alaska Natives Seeking Substance Use Treatment in an Urban Setting: A Descriptive Study

We analyze substance use, AI/AN cultural identity and involvement, physical health and cognitive functioning, and mental health symptoms among 63 AI/AN adults seeking substance use treatment within an urban area in California.

Feb 18, 2021
Journal Article

Current U.S. State Cannabis Sales Limits Allow Large Doses for Use or Diversion

This cross-sectional study examined how transaction sales limits on recreational cannabis translate to tetrahydrocannabinol doses among U.S. states allowing commercial cannabis sales as of January 1, 2020.

Feb 17, 2021
Journal Article

Patterns of Substance Use and Associations with Mental, Physical, and Social Functioning: A Latent Class Analysis of a National Sample of U.S. Adults Ages 30–80

This study identifies distinct patterns (classes) of substance use among 30- to 80-year olds, identifies demographic subgroups with the highest probability of class memberships, and compares classes on key indicators of functioning.

Feb 10, 2021
Multimedia

Opioid Litigation: What's New, and What Does It Mean for Future Litigation?

More than 2,000 plaintiffs have joined the largest civil trial in U.S. history: National Prescription Opiate Litigation (MDL 2804). In this virtual symposium, experts discuss the opioid litigation and its effects on the future of mass litigation.

Feb 9, 2021
Multimedia

RAND Remote: High Stakes, Fostering Innovation to Stem the Tide of America's Drug Problems

In this RAND Remote presentation, Beau Kilmer discusses how RAND is identifying and evaluating innovative approaches to tackle some of America's most pressing drug problems and help strengthen and safeguard communities.

Jan 28, 2021
Multimedia

State-Level Opioid Policy Analyses: Moving Beyond the Classic Difference-in-Difference Model

Researchers affiliated with the RAND-USC Schaeffer Opioid Policy Tools and Information Center (OPTIC) present a webinar on methods for evaluating the effectiveness of state-level policy.

Jan 26, 2021

1
2
3
4
5
6
7
8
9
10
Next

Research conducted by